These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38303987)

  • 1. Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis.
    Meregildo-Rodriguez ED; Asmat-Rubio MG; Bardales-Zuta VH; Vásquez-Tirado GA
    Front Pharmacol; 2024; 15():1298919. PubMed ID: 38303987
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers for inhibiting preterm labour and birth.
    Flenady V; Wojcieszek AM; Papatsonis DN; Stock OM; Murray L; Jardine LA; Carbonne B
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002255. PubMed ID: 24901312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Calcium Channel Blockers and Risk of Active Tuberculosis Disease: A Population-Based Analysis.
    Lee CC; Lee MG; Hsu WT; Park JY; Porta L; Liu MA; Chen SC; Chang SC
    Hypertension; 2021 Feb; 77(2):328-337. PubMed ID: 33307850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Optimal Glycemic Control on Tuberculosis Treatment Outcomes in Patients With Diabetes Mellitus: Systematic Review and Meta-Analysis.
    Zhao L; Gao F; Zheng C; Sun X
    JMIR Public Health Surveill; 2024 Apr; 10():e53948. PubMed ID: 38564244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers for primary and secondary Raynaud's phenomenon.
    Rirash F; Tingey PC; Harding SE; Maxwell LJ; Tanjong Ghogomu E; Wells GA; Tugwell P; Pope J
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD000467. PubMed ID: 29237099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers versus other classes of drugs for hypertension.
    Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.
    Zhou YT; Yu LS; Zeng S; Huang YW; Xu HM; Zhou Q
    Ther Clin Risk Manag; 2014; 10():17-26. PubMed ID: 24379677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies.
    Hussain S; Singh A; Rahman SO; Habib A; Najmi AK
    Neurosci Lett; 2018 Apr; 671():120-127. PubMed ID: 29452176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.
    Rotshild V; Azoulay L; Zarifeh M; Masarwa R; Hirsh-Raccah B; Perlman A; Muszkat M; Matok I
    Drug Saf; 2018 Jun; 41(6):555-564. PubMed ID: 29484611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleeding.
    He Y; Chan EW; Leung WK; Anand S; Wong IC
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1246-55. PubMed ID: 25898902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk for Prostate Cancer With Calcium Channel Blockers: A Systematic Review, Meta-Analysis, and Meta-Regression.
    Rotshild V; Rabkin N; Matok I
    Ann Pharmacother; 2023 Jan; 57(1):16-28. PubMed ID: 35645169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Oral Antidiabetic Drugs on Tuberculosis Risk and Treatment Outcomes: Systematic Review and Meta-Analysis.
    Meregildo-Rodriguez ED; Asmat-Rubio MG; Zavaleta-Alaya P; Vásquez-Tirado GA
    Trop Med Infect Dis; 2022 Oct; 7(11):. PubMed ID: 36355885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
    Washam JB; Hellkamp AS; Lokhnygina Y; Piccini JP; Berkowitz SD; Nessel CC; Becker RC; Breithardt G; Fox KAA; Halperin JL; Hankey GJ; Mahaffey KW; Singer DE; Patel MR;
    Am J Cardiol; 2017 Aug; 120(4):588-594. PubMed ID: 28645473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.